Transcriptional suppression of androgen receptor by 18β-glycyrrhetinic acid in LNCaP human prostate cancer cells

[1]  Jun Li,et al.  MicroRNA‐488 inhibits proliferation and glycolysis in human prostate cancer cells by regulating PFKFB3 , 2019, FEBS open bio.

[2]  Ri-zhen Huang,et al.  Discovery of 18β-glycyrrhetinic acid conjugated aminobenzothiazole derivatives as Hsp90-Cdc37 interaction disruptors that inhibit cell migration and reverse drug resistance. , 2018, Bioorganic & medicinal chemistry.

[3]  Min Zhang,et al.  MiR-488 suppresses cell proliferation and invasion by targeting ADAM9 and lncRNA HULC in hepatocellular carcinoma. , 2017, American journal of cancer research.

[4]  J. Miano,et al.  Testosterone Rescues the De‐Differentiation of Smooth Muscle Cells Through Serum Response Factor/Myocardin , 2017, Journal of cellular physiology.

[5]  Jiahui Gu,et al.  microRNA-488 inhibits chemoresistance of ovarian cancer cells by targeting Six1 and mitochondrial function , 2017, Oncotarget.

[6]  S. Fan,et al.  Blocking autophagy enhances the apoptotic effect of 18β-glycyrrhetinic acid on human sarcoma cells via endoplasmic reticulum stress and JNK activation , 2017, Cell Death and Disease.

[7]  G. Evan,et al.  Determination of the physiological and pathological roles of E2F3 in adult tissues , 2017, Scientific Reports.

[8]  Yan Shi,et al.  Histone demethylase PHF8 accelerates the progression of colorectal cancer and can be regulated by miR-488 in vitro , 2017, Molecular medicine reports.

[9]  Wei Zhang,et al.  MiR-488 inhibits proliferation and cisplatin sensibility in non-small-cell lung cancer (NSCLC) cells by activating the eIF3a-mediated NER signaling pathway , 2017, Scientific Reports.

[10]  T. Tsukamoto,et al.  18β-glycyrrhetinic acid suppresses gastric cancer by activation of miR-149-3p-Wnt-1 signaling , 2016, Oncotarget.

[11]  M. Ren,et al.  miR-488 acts as a tumor suppressor gene in gastric cancer , 2016, Tumor Biology.

[12]  C. Avendaño,et al.  Swept-sine noise-induced damage as a hearing loss model for preclinical assays , 2015, Front. Aging Neurosci..

[13]  G. Yen,et al.  Protective Effects of Glycyrrhizic Acid and 18β-Glycyrrhetinic Acid against Cisplatin-Induced Nephrotoxicity in BALB/c Mice. , 2015, Journal of agricultural and food chemistry.

[14]  P. Park,et al.  Baicalein induces autophagic cell death through AMPK/ULK1 activation and downregulation of mTORC1 complex components in human cancer cells , 2014, The FEBS journal.

[15]  M. Rahmani,et al.  Glycyrrhetinic Acid inhibits cell growth and induces apoptosis in ovarian cancer a2780 cells. , 2014, Advanced pharmaceutical bulletin.

[16]  Susan S. Brown,et al.  Regulation of the transcriptional coactivator FHL2 licenses activation of the androgen receptor in castrate-resistant prostate cancer. , 2013, Cancer research.

[17]  Wenxiu Zhao,et al.  18β‐glycyrrhetinic acid inhibits hepatocellular carcinoma development by reversing hepatic stellate cell‐mediated immunosuppression in mice , 2013, International journal of cancer.

[18]  J. Papadimitriou,et al.  Inhibition of Mcl-1 Promotes Senescence in Cancer Cells: Implications for Preventing Tumor Growth and Chemotherapy Resistance , 2012, Molecular and Cellular Biology.

[19]  M. Day,et al.  Repression of Androgen Receptor Transcription through the E2F1/DNMT1 Axis , 2011, PloS one.

[20]  A. Kajdacsy-Balla,et al.  18α-glycyrrhetinic acid targets prostate cancer cells by down-regulating inflammation-related genes. , 2011, International journal of oncology.

[21]  Rajesh Singh,et al.  miR 488* inhibits androgen receptor expression in prostate carcinoma cells , 2011, International journal of cancer.

[22]  R. Chakrabarti,et al.  Androgen regulates Cdc6 transcription through interactions between androgen receptor and E2F transcription factor in prostate cancer cells. , 2008, Biochimica et biophysica acta.

[23]  R. Slack,et al.  Specific In Vivo Roles for E2Fs in Differentiation and Development , 2007, Cell cycle.

[24]  M. Taplin.  Drug Insight: role of the androgen receptor in the development and progression of prostate cancer , 2007, Nature Clinical Practice Oncology.

[25]  David G Johnson,et al.  Distinct and Overlapping Roles for E2F Family Members in Transcription, Proliferation and Apoptosis. , 2006, Current molecular medicine.

[26]  R. Schwartz,et al.  Recruitment of the Androgen Receptor via Serum Response Factor Facilitates Expression of a Myogenic Gene* , 2005, Journal of Biological Chemistry.

[27]  I. Takenaka,et al.  Identification of novel functional inhibitors of 17beta-hydroxysteroid dehydrogenase type III (17beta-HSD3). , 2005, The Prostate.

[28]  S. Balk,et al.  Androgen receptor: A key molecule in the progression of prostate cancer to hormone independence , 2004, Journal of cellular biochemistry.

[29]  P. Shastry,et al.  Upregulation of survivin in G2/M cells and inhibition of caspase 9 activity enhances resistance in staurosporine-induced apoptosis. , 2004, Neoplasia.

[30]  M. Schoenberg,et al.  Androgen-receptor gene structure and function in prostate cancer , 2004, World Journal of Urology.

[31]  Stefania Staibano,et al.  Expression of epidermal growth factor receptor correlates with disease relapse and progression to androgen-independence in human prostate cancer. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

[32]  Jeffrey M. Trimarchi,et al.  Transcription: Sibling rivalry in the E2F family , 2002, Nature Reviews Molecular Cell Biology.

[33]  N. Harada,et al.  Incomplete testicular feminization syndrome: studies on androgen receptor(AR) function, AR gene analysis, and aromatase activities at puberty and long-term observations of clinical and hormonal features from infancy to puberty. , 1996, Endocrine journal.

[34]  G. Buchanan,et al.  Mutations in the androgen receptor gene are associated with progression of human prostate cancer to androgen independence. , 1996, Clinical cancer research : an official journal of the American Association for Cancer Research.

[35]  Jorma Isola,et al.  In vivo amplification of the androgen receptor gene and progression of human prostate cancer , 1995, Nature Genetics.